Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 56, Issue 1

Issues

An abnormal elevation of serum CA72-4 due to taking colchicine

Bing Zhao
  • Department of Laboratory Medicine, Taizhou First People’s Hospital, Huangyan Hospital Affiliated to Wenzhou Medical University, Zhejiang, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Miaomiao Zhang
  • Department of Laboratory Medicine, Taizhou First People’s Hospital, Huangyan Hospital Affiliated to Wenzhou Medical University, Zhejiang, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Jing Xie
  • Department of Laboratory Medicine, Taizhou First People’s Hospital, Huangyan Hospital Affiliated to Wenzhou Medical University, Zhejiang, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yingpeng Ren
  • Department of Laboratory Medicine, Taizhou First People’s Hospital, Huangyan Hospital Affiliated to Wenzhou Medical University, Zhejiang, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Yan Liang
  • Department of Laboratory Diagnostics, Changzheng Hospital, Second Military Medical University, Shanghai, P.R. China
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Zaixing Yang
  • Corresponding author
  • Department of Laboratory Medicine, Taizhou First People’s Hospital, Huangyan Hospital Affiliated to Wenzhou Medical University, Zhejiang, P.R. China
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2017-07-05 | DOI: https://doi.org/10.1515/cclm-2017-0399

Keywords: CA72-4; colchicine; gout

References

  • 1.

    Byrne DJ, Browning MC, Cuschieri A. CA72-4: a new tumour marker for gastric cancer. Br J Surg 1990;77:1010–3.CrossrefPubMedGoogle Scholar

  • 2.

    Liang Y, Wang W, Fang C, Raj SS, Hu WM, Li QW, Zhou ZW. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Oncotarget 2016;7:49565–73.Web of ScienceCrossrefPubMedGoogle Scholar

  • 3.

    Yu J, Zhang S, Zhao B. Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer. Mol Clin Oncol 2016;4:441–9.PubMedCrossrefGoogle Scholar

  • 4.

    Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 2014;17:26–33.CrossrefWeb of ScienceGoogle Scholar

  • 5.

    Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 2000;16:105–10.PubMedCrossrefGoogle Scholar

  • 6.

    Byström P, Berglund A, Nygren P, Wernroth L, Johansson B, Larsson A, et al. An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer. Oncol Rep 2010;24:1645–52.PubMedWeb of ScienceGoogle Scholar

  • 7.

    Wang Z, Tian YP. Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. Mol Clin Oncol 2014;2:265–8.CrossrefGoogle Scholar

  • 8.

    Terry KL, Schock H, Fortner RT, Hüsing A, Fichorova RN, Yamamoto HS, et al. A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC Cohort. Clin Cancer Res 2016;22:4664–75.Web of ScienceCrossrefPubMedGoogle Scholar

  • 9.

    Anastasi E, Manganaro L, Granato T, Benedetti Panici P, Frati L, Porpora MG. Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? Dis Markers 2013;35:331–5.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 10.

    Li ZY, Sun LH. Abnormal elevation of serum CA72-4 by mushroom: a case report. Chin J Lab Med 2011;34:180–1.Google Scholar

  • 11.

    Liang Y, He M, Fan X, Ye W, Yang Z, Zhong R. An abnormal elevation of serum CA72-4 by ganoderma lucidum spore powder. Ann Clin Lab Sci 2013;43:337–40.PubMedGoogle Scholar

  • 12.

    Yan B, Meng X, Shi J, Qin Z, Wei P, Lao L. Ganoderma lucidum spore induced CA72-4 elevation in gastrointestinal cancer: a five-case report. Integr Cancer Ther 2014;13:161–6.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 13.

    Nuki G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep 2008;10:218–27.CrossrefPubMedGoogle Scholar

  • 14.

    Hartung EF. Colchicine and its analogs in gout: a brief review. Arthritis Rheum 1961;4:18–26.CrossrefGoogle Scholar

  • 15.

    Kesselheim AS, Solomon DH. Incentives for drug development–the curious case of colchicine. N Engl J Med 2010;362:2045–7.CrossrefPubMedGoogle Scholar

  • 16.

    Kuo MC, Chang SJ, Hsieh MC. Colchicine significantly reduces incident cancer in gout male patients: a 12-year cohort study. Medicine (Baltimore) 2015;94:e1570.Web of SciencePubMedCrossrefGoogle Scholar

About the article

Bing Zhao and Miaomiao Zhang contributed equally to this work.


Received: 2017-03-22

Accepted: 2017-05-26

Published Online: 2017-07-05

Published in Print: 2017-11-27


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: This study was supported by the grant from the National Natural Science Foundation Council (81671594).

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 56, Issue 1, Pages e13–e15, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2017-0399.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in